IL6 and breast cancer: Our data showed that this compound reduced the expression of IL-6 mRNA and STAT3, which promote proliferation, metastasis, invasion, and angiogenesis in breast cancers, and could result in the suppression of the NF-kB/IL-6/JAK2/STAT3 signaling pathway.